Can a simple blood test predict COPD Flare-Up severity?
NCT ID NCT07734883
First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time
Summary
This study tracks people over 40 hospitalized for a COPD flare-up to see how many have a type called eosinophilic COPD, marked by higher levels of certain white blood cells. Researchers will compare hospital stay length and need for breathing support between those with and without this type. The goal is to better understand whether this difference matters for recovery and future treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If this study clarifies how eosinophilic COPD affects flare-ups, it could help doctors tailor treatments for better outcomes.
- What could go wrong
- This is a small, single-center observational study, so findings may not apply to all COPD patients. It does not test any new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New inhaled compound aims to ease COPD breathing woes
- Ultrasound might reveal hidden lung damage in COPD
- Putting Patients' priorities first: a new approach to ease the burden of multiple chronic illnesses
- Can a gentle nasal breeze unclog the Lungs' smallest airways?
- Can Home-Based lung rehab win over more COPD patients?
- Breathing battle: can simple exercises ease COPD symptoms?